Ahmed AU, Thaci B, Alexiades NG et al (2011) Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma. Mol Ther. 19:1714–26. https://doi.org/10.1038/mt.2011.100

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahmed AU, Thaci B, Tobias AL et al (2013) A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy. J Natl Cancer Inst. 105:968–77. https://doi.org/10.1093/jnci/djt141

Article  CAS  PubMed  PubMed Central  Google Scholar 

Association ABT (2023) Classification of Brain Tumors. https://www.abta.org

Bahadure NB, Ray AK, Thethi HP (2018) Comparative Approach of MRI-Based Brain Tumor Segmentation and Classification Using Genetic Algorithm. J Digit Imaging. 31:477–89. https://doi.org/10.1007/s10278-018-0050-6

Article  PubMed  PubMed Central  Google Scholar 

Bale TA, Rosenblum MK (2022) The 2021 WHO classification of tumors of the central nervous system: an update on pediatric low-grade gliomas and glioneuronal tumors. Brain Pathol 32:e13060

Article  PubMed  PubMed Central  Google Scholar 

Beasley GM, Nair SK, Farrow NE et al (2021) Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma. J Immunother Cancer. https://doi.org/10.1136/jitc-2020-002203

Article  PubMed  PubMed Central  Google Scholar 

Béguin J, Nourtier V, Gantzer M et al (2020) Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs. BMC Vet Res. 16:307. https://doi.org/10.1186/s12917-020-02524-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Béguin J, Foloppe J, Maurey C et al (2020) preclinical evaluation of the oncolytic vaccinia virus tg6002 by translational research on canine breast cancer. Mol Ther Oncolytics. 19:57–66. https://doi.org/10.1016/j.omto.2020.08.020

Article  CAS  PubMed  PubMed Central  Google Scholar 

Béguin J, Gantzer M, Farine I, Foloppe J, Klonjkowski B, Maurey C, Quéméneur É, Erbs P (2021) Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs. Sci Rep. 11:2209. https://doi.org/10.1038/s41598-021-81831-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berzero G, Di Stefano AL, Ronchi S et al (2021) IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification. Neuro Oncol. 23:955–66. https://doi.org/10.1093/neuonc/noaa258

Article  CAS  PubMed  Google Scholar 

Bhatt DK, Chammas R, Daemen T (2021) Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic Analysis. Vaccines (Basel). https://doi.org/10.3390/vaccines9101166

Article  PubMed  Google Scholar 

Bortolanza S, Bunuales M, Otano I, Gonzalez-Aseguinolaza G, Ortiz-de-Solorzano C, Perez D, Prieto J, Hernandez-Alcoceba R (2009) Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters. Mol Ther. 17:614–22. https://doi.org/10.1038/mt.2009.9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brat DJ, Aldape K, Colman H et al (2020) cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathol. 139:603–8. https://doi.org/10.1007/s00401-020-02127-9

Article  PubMed  PubMed Central  Google Scholar 

Cairncross G, Wang M, Shaw E et al (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol. 31:337–43. https://doi.org/10.1200/jco.2012.43.2674

Article  CAS  PubMed  Google Scholar 

Cassady KA, Bauer DF, Roth J, Chambers MR, Shoeb T, Coleman J, Prichard M, Gillespie GY, Markert JM (2017) Pre-clinical assessment of C134, a chimeric oncolytic herpes simplex virus, in mice and non-human primates. Mol Ther Oncolytics. 5:1–10. https://doi.org/10.1016/j.omto.2017.02.001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chambers MR, Bentley RT, Crossman DK et al (2020) The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in combination with a checkpoint inhibitor in canine patients with sporadic high grade gliomas. Front Surg. 7:59. https://doi.org/10.3389/fsurg.2020.00059

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chastkofsky MI, Pituch KC, Katagi H et al (2021) Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma. Clin Cancer Res. 27:1766–77. https://doi.org/10.1158/1078-0432.Ccr-20-1499

Article  CAS  PubMed  Google Scholar 

Chen Y-H, Fik T (2017) Housing-market bubble adjustment in coastal communities - A spatial and temporal analysis of housing prices in Midwest Pinellas County, Florida. Appl Geogr 80:48–63. https://doi.org/10.1016/j.apgeog.2017.01.007

Article  Google Scholar 

Chianese A, Santella B, Ambrosino A, Stelitano D, Rinaldi L, Galdiero M, Zannella C, Franci G (2021) Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives. Cancers (Basel). https://doi.org/10.3390/cancers13112761

Article  PubMed  Google Scholar 

Chiocca EA, Yu JS, Lukas RV et al (2019) Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aaw5680

Article  PubMed  PubMed Central  Google Scholar 

Chiocca EA, Nakashima H, Kasai K, Fernandez SA, Oglesbee M (2020) Preclinical Toxicology of rQNestin34.5v.2: An Oncolytic Herpes Virus with Transcriptional Regulation of the ICP34.5 Neurovirulence Gene. Mol Ther Methods Clin Dev. 17:871–93. https://doi.org/10.1016/j.omtm.2020.03.028

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chovatiya N, Kaur K, Huerta-Yepez S, Chen P-C, Neal A, DiBernardo G, Gumrukcu S, Memarzadeh S, Jewett A (2022) Inability of ovarian cancers to upregulate their MHC-class I surface expression marks their aggressiveness and increased susceptibility to NK cell-mediated cytotoxicity. Cancer Immunol Immunother 71:2929–41

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cicirò Y, Sala A (2021) MYB oncoproteins: emerging players and potential therapeutic targets in human cancer. Oncogenesis. 10:19

Article  PubMed  PubMed Central  Google Scholar 

Coffin R (2016) Interview with Robert Coffin, inventor of T-VEC: the first oncolytic immunotherapy approved for the treatment of cancer. Immunotherapy. 8:103–6

Article  CAS  PubMed  Google Scholar 

Cristi F, Gutiérrez T, Hitt MM, Shmulevitz M (2022) Genetic Modifications That Expand Oncolytic Virus Potency. Front Mol Biosci 9:831091. https://doi.org/10.3389/fmolb.2022.831091

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Felice F, Giudice E, Bolomini G, Distefano MG, Scambia G, Fagotti A, Marchetti C (2021) Pembrolizumab for advanced cervical cancer: safety and efficacy. Expert Rev Anticancer Ther. 21:221–8. https://doi.org/10.1080/14737140.2021.1850279

Article  CAS  PubMed  Google Scholar 

Denniston E, Crewdson H, Rucinsky N et al (2016) The practical consideration of poliovirus as an oncolytic virotherapy. Am J Virol. 5:1–7. https://doi.org/10.3844/ajvsp.2016.1.7

Article  PubMed  PubMed Central  Google Scholar 

Desjardins A, Gromeier M, Herndon JE 2nd et al (2018) Recurrent glioblastoma treated with recombinant poliovirus. N Engl J Med. 379:150–61. https://doi.org/10.1056/NEJMoa1716435

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding H, Wang G, Yu Z, Sun H, Wang L (2022) Role of interferon-gamma (IFN-γ) and IFN-γ receptor 1/2 (IFNγR1/2) in regulation of immunity, infection, and cancer development: IFN-γ-dependent or independent pathway. Biomed Pharmacother 155:113683

Article  CAS  PubMed  Google Scholar 

Dong H, Li M, Yang C, Wei W, He X, Cheng G, Wang S (2023) Combination therapy with oncolytic viruses and immune checkpoint inhibitors in head and neck squamous cell carcinomas: an approach of complementary advantages. Cancer Cell Int. 23:1. https://doi.org/10.1186/s12935-022-02846-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dougan M, Dranoff G, Dougan SK (2019) GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation. Immunity. 50:796–811. https://doi.org/10.1016/j.immuni.2019.03.022

Article  CAS  PubMed  Google Scholar 

Fares J, Ahmed AU, Ulasov IV et al (2021) Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial. Lancet Oncol. 22:1103–14. https://doi.org/10.1016/s1470-2045(21)00245-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Figarella-Branger D, Mokhtari K, Dehais C et al (2014) Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations. Neuro Oncol. 16:1244–54. https://doi.org/10.1093/neuonc/nou047